HCM
CDLX icon

Harspring Capital Management’s Cardlytics CDLX Stock Holding History

Harspring Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,238
Closed -$4.62M – 36
2020
Q4 		$4.62M Sell
3,238
-4,850
-60% -$5.17M 0.95% 29
2020
Q3 		$5.71M Buy
8,088
+3,018
+60% +$2.19M 1.58% 23
2020
Q2 		$3.55M Sell
5,070
-10,000
-66% -$5.77M 1.2% 20
2020
Q1 		$5.27M Buy
+15,070
New +$10.7M 2.94% 11

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Harspring Capital Management's CDLX Position: Q1 2021 in Review

Harspring Capital Management sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 3,238 shares — an estimated $4.62M sold.

Harspring Capital Management first reported a position in CDLX in Q1 2020 and held it in 4 quarters. The position peaked at $5.71M in Q3 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • Harspring Capital Management reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
  • Harspring Capital Management sold 3,238 Cardlytics shares in Q1 2021, an estimated $4.62M.
  • Harspring Capital Management first reported a position in Cardlytics in Q1 2020 and held it in 4 quarters.
  • Harspring Capital Management's Cardlytics position peaked at $5.71M in Q3 2020.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Harspring Capital Management's 13F filing for Q1 2021, filed 14 May 2021.